Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302 Citation: Teply BA, Qiu F, Antonarakis ES, et al. Prostate. 2019 Jun;79(8):929-933. PMID: 31059588.
The YODA Project